← Open Payments lookup

NPI 1669407847: Open Payments

NPI 1669407847. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$906 in 38 payments from 11 companies in 2025. Trend: 2023 $602 · 2024 $922 · 2025 $906

Food & beverage: $906
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.7$201
Vanda Pharmaceuticals Inc.7$193
Collegium Pharmaceutical, Inc.6$119
Corium, LLC3$86
ABBVIE INC.4$69
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$69
Almatica Pharma LLC3$49
Tris Pharma Inc2$47
E.R. Squibb & Sons, L.L.C.1$28
IDORSIA PHARMACEUTICALS US INC1$23

Products named: Qelbree, HETLIOZ, Jornay PM, Azstarys, VRAYLAR, CAPLYTA, LOREEV XR, Dyanavel XR.